EpirubicinThird Party Manufacturing in India

Epirubicin works by directly entering cancer cells and disrupting their ability to copy and repair their DNA, thereby stopping tumor growth.

As an anthracycline antineoplastic agent, Epirubicin exerts its effects through multiple cellular pathways. It intercalates between adjacent base pairs of the DNA double helix, which physically blocks the replication and transcription enzymes. It binds to and inhibits topoisomerase II, an enzyme crucial for maintaining DNA structure during cell division. By stabilizing the DNA-enzyme cleavage complex, Epirubicin prevents DNA strands from resealing, causing double-stranded DNA breaks. Additionally, it undergoes cellular reduction to generate reactive oxygen species that damage lipid membranes and cellular proteins.

Unlike traditional alkylating agents, Epirubicin acts during multiple phases of the cell cycle, offering broad efficacy against rapidly dividing tumor cells. It is widely utilized in oncology regimens because of its slightly better safety profile and lower cardiotoxicity compared to its parent compound, doxorubicin.

Epirubicin (CAS 56390-09-1) is a critical anthracycline chemotherapy agent widely utilized in oncology care. Celesta provides high-quality solutions for Epirubicin third party manufacturing in India, supplying global markets with sterile injectable formulations.

Therapeutic Uses

Epirubicin is prescribed for the treatment of:

• Breast Cancer: Used as an adjuvant treatment in patients with node-positive breast cancer following surgical resection of the primary tumor.
• Gastric Cancer: Employed in combination chemotherapy regimens for advanced or metastatic stomach cancers.
• Ovarian and Uterine Cancers: Utilized in treatment protocols for advanced gynecological malignancies.
• Small Cell Lung Cancer: Used as part of multi-agent chemotherapy regimens for systemic management.
• Lymphomas: Included in combination therapies for Hodgkin's and non-Hodgkin's lymphomas.

Choosing an Epirubicin Manufacturer in India

Epirubicin is a key chemotherapy drug listed on the World Health Organization (WHO) Model List of Essential Medicines. It remains a standard of care globally for breast cancer treatments, ensuring steady demand from institutional oncology departments, government tenders, and export markets. For pharmaceutical distributors, partnering with a reliable Epirubicin manufacturer is key to entering the specialized oncology tender market. Because it is a cytotoxic drug, formulation requires dedicated high-containment suites in WHO-GMP certified facilities to ensure absolute operator safety and zero cross-contamination. Sourcing Epirubicin injection from a WHO-GMP certified partner in India guarantees sterile, pyrogen-free vials that comply with international pharmacopoeias.

To place an order or discuss customization, please contact our team. You can view all our oncology injectables on our manufacturing listing page or learn about our service offerings on our contract manufacturing page.

This makes Epirubicin one of the most sought-after oncology molecules for third party manufacturing in India, with consistent demand from specialized oncology clinics and export-oriented distributors.